Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02170181 · ClinicalTrials.gov registry record
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 149
- Enrollment target
NCT02170181: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT02170181 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 149 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02170181 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 149 participants
- Enrollment target
Study Summary
This prospective protocol will enroll patients with pathologically confirmed solid malignancies who receive stereotactic body radiation therapy (SBRT) for oligometastases, for consolidation after systemic therapy, prior to systemic therapy for the purposes of debulking, or in the re-irradiation setting. Increasing use of SBRT off of clinical trials in patients with malignancies of all histologies is being utilized in these settings. However, individualized outcomes and characteristics of treatments are not prospectively followed and not well documented. By instituting a registry of patients receiving SBRT in these settings it will be possible to determine trends in patterns of care and outcomes for refinement and justification of this treatment.
Primary Outcome
Prospectively enroll patients to one of four treatment categories who are to receive SBRT onto a registry to define patterns of care: Group 1: Oligometastatic disease- all radiologic suspicious areas for viable disease to be treated Group 2: Consolidation Therapy - only PET avid or progressive disease Group 3: Norton-Simon Arm - SBRT prior to initial of planned further systemic therapy Group 4: Re-Irradiation Arm-recurrence or failure within a previously irradiated volume.
Interventions
- RADIATION SBRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2014-05-28 |
| Est. Completion | 2025-08 |
What the finished NCT02170181 record still lists
NCT02170181 is an observational study that tracks outcomes without assigning an intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which SBRT is the first listed.
NCT02170181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02170181 about?
NCT02170181 is a clinical study titled "Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation". This prospective protocol will enroll patients with pathologically confirmed solid malignancies who receive stereotactic body radiation therapy (SBRT) for oligometastases, for consolidation after systemic therapy, prior to systemic therapy for the purposes of debulking, or in the re-irradiation sett...
What is the current status of trial NCT02170181?
This trial is currently completed. The enrollment target is 149 participants. The study started on 2014-05-28. Estimated completion is 2025-08.
What interventions are being tested in trial NCT02170181?
The interventions under investigation include: SBRT (RADIATION).
Who is sponsoring clinical trial NCT02170181?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI